LY3471851
17238
Phase 2 small_molecule completed
Quick answer
LY3471851 for Systemic Lupus Erythematosus is a Phase 2 program (small_molecule) at NEKTAR THERAPEUTICS with 2 ClinicalTrials.gov record(s).
Program details
- Company
- NEKTAR THERAPEUTICS
- Indication
- Systemic Lupus Erythematosus
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed